G E Sonenshein

2.6k total citations · 1 hit paper
16 papers, 2.3k citations indexed

About

G E Sonenshein is a scholar working on Cancer Research, Molecular Biology and Immunology. According to data from OpenAlex, G E Sonenshein has authored 16 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 9 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in G E Sonenshein's work include NF-κB Signaling Pathways (13 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Immune Response and Inflammation (3 papers). G E Sonenshein is often cited by papers focused on NF-κB Signaling Pathways (13 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Immune Response and Inflammation (3 papers). G E Sonenshein collaborates with scholars based in United States. G E Sonenshein's co-authors include Marcello Arsura, Dong Wook Kim, Robert E. Bellas, Abdulmaged M. Traish, Mika A. Sovak, Gregory Zanieski, Mabel P. Duyao, Adrianne E. Rogers, Alan Buckler and Min Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

G E Sonenshein

16 papers receiving 2.2k citations

Hit Papers

Aberrant nuclear factor-kappaB/Rel expression and the pat... 1997 2026 2006 2016 1997 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G E Sonenshein United States 15 1.3k 1.2k 708 698 135 16 2.3k
Robert E. Bellas United States 15 1.2k 0.9× 1.1k 0.9× 700 1.0× 504 0.7× 96 0.7× 18 2.0k
Marcello Arsura United States 25 2.1k 1.6× 1.4k 1.1× 882 1.2× 943 1.4× 152 1.1× 36 3.1k
Nywana Sizemore United States 20 1.3k 1.0× 836 0.7× 798 1.1× 625 0.9× 104 0.8× 31 2.5k
Manfred Hergenhahn Germany 26 1.3k 1.0× 385 0.3× 623 0.9× 684 1.0× 338 2.5× 51 2.5k
Rebecca J. Gum United States 23 1.6k 1.2× 704 0.6× 324 0.5× 508 0.7× 81 0.6× 31 2.4k
Shine‐Gwo Shiah Taiwan 31 1.9k 1.4× 818 0.7× 556 0.8× 673 1.0× 85 0.6× 54 2.8k
Takeshi Iwamura Japan 22 1.1k 0.8× 444 0.4× 260 0.4× 697 1.0× 102 0.8× 44 2.0k
Hasem Habelhah United States 23 1.6k 1.2× 722 0.6× 445 0.6× 426 0.6× 120 0.9× 37 2.1k
Lisiane B. Meira United States 31 2.0k 1.5× 653 0.5× 180 0.3× 648 0.9× 261 1.9× 61 2.6k
Rinnat M. Porat Israel 8 1.1k 0.9× 858 0.7× 721 1.0× 725 1.0× 107 0.8× 10 2.4k

Countries citing papers authored by G E Sonenshein

Since Specialization
Citations

This map shows the geographic impact of G E Sonenshein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G E Sonenshein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G E Sonenshein more than expected).

Fields of papers citing papers by G E Sonenshein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G E Sonenshein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G E Sonenshein. The network helps show where G E Sonenshein may publish in the future.

Co-authorship network of co-authors of G E Sonenshein

This figure shows the co-authorship network connecting the top 25 collaborators of G E Sonenshein. A scholar is included among the top collaborators of G E Sonenshein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G E Sonenshein. G E Sonenshein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pianetti, Stefania, Marcello Arsura, Raphaëlle Romieu‐Mourez, Robert J. Coffey, & G E Sonenshein. (2001). Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN. Oncogene. 20(11). 1287–1299. 228 indexed citations
2.
Landesman‐Bollag, Esther, et al.. (2001). Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.. PubMed. 61(9). 3810–8. 137 indexed citations
3.
Kim, Dong Wook, et al.. (2000). The RelA NF-κB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene. 19(48). 5498–5506. 232 indexed citations
4.
Sovak, Mika A., et al.. (1999). The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.. PubMed. 10(8). 537–44. 82 indexed citations
5.
Wu, Min, William Yang, Robert E. Bellas, et al.. (1997). c-Myc Promotes Survival of WEHI 231 B Lymphoma Cells from Apoptosis. Current topics in microbiology and immunology. 224. 91–101. 21 indexed citations
6.
Sovak, Mika A., Robert E. Bellas, Dong Wook Kim, et al.. (1997). Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.. Journal of Clinical Investigation. 100(12). 2952–2960. 613 indexed citations breakdown →
7.
Arsura, Marcello, Mark J. Fitzgerald, N Fausto, & G E Sonenshein. (1997). Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines.. PubMed. 8(10). 1049–59. 90 indexed citations
8.
Bellas, Robert E., Mark J. Fitzgerald, N Fausto, & G E Sonenshein. (1997). Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes.. PubMed. 151(4). 891–6. 138 indexed citations
9.
Arsura, Marcello, Min Wu, & G E Sonenshein. (1996). TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBα. Immunity. 5(1). 31–40. 228 indexed citations
11.
Kessler, D. J., Mabel P. Duyao, Douglas B. Spicer, & G E Sonenshein. (1992). NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts.. The Journal of Experimental Medicine. 176(3). 787–792. 99 indexed citations
12.
Kessler, D. J., et al.. (1992). A novel NF-kappa B element within exon 1 of the murine c-myc gene.. PubMed. 7(12). 2447–53. 27 indexed citations
13.
Maheswaran, Shyamala, James E. McCormack, & G E Sonenshein. (1991). Changes in phosphorylation of myc oncogene and RB antioncogene protein products during growth arrest of the murine lymphoma WEHI 231 cell line.. PubMed. 6(11). 1965–71. 29 indexed citations
14.
Buckler, Alan, Thomas L. Rothstein, & G E Sonenshein. (1990). Transcriptional control of c- myc gene expression during stimulation of murine B lymphocytes.. The Journal of Immunology. 145(2). 732–736. 5 indexed citations
15.
Duyao, Mabel P., Alan Buckler, & G E Sonenshein. (1990). Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.. Proceedings of the National Academy of Sciences. 87(12). 4727–4731. 235 indexed citations
16.
Buckler, Alan, Henri Vié, G E Sonenshein, & R A Miller. (1988). Defective T lymphocytes in old mice. Diminished production of mature c- myc RNA after mitogen exposure not attributable to alterations in transcription or RNA stability.. The Journal of Immunology. 140(7). 2442–2446. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026